Molgramostim shows promise in rare lung disease treatment
LANGHORNE, Pa. - Savara Inc. (NASDAQ:SVRA), a biopharmaceutical company specializing in rare respiratory diseases with a ...
Medscape5 天
The Hypoxic Tumor Microenvironment: Driving the Tumorigenesis of Non-small-cell Lung Cancer
Since the application of molecular biology in cancer biology, lung cancer research has classically focused on molecular drivers of disease. One such pathway, the hypoxic response pathway, is ...